4-((3-aminopropyl)amino)-5-(3,5-dimethylphenyl)-N-(3-hydroxyphenyl)nicotinamide

ID: ALA5271468

Chembl Id: CHEMBL5271468

Max Phase: Preclinical

Molecular Formula: C23H26N4O2

Molecular Weight: 390.49

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1cc(C)cc(-c2cncc(C(=O)Nc3cccc(O)c3)c2NCCCN)c1

Standard InChI:  InChI=1S/C23H26N4O2/c1-15-9-16(2)11-17(10-15)20-13-25-14-21(22(20)26-8-4-7-24)23(29)27-18-5-3-6-19(28)12-18/h3,5-6,9-14,28H,4,7-8,24H2,1-2H3,(H,25,26)(H,27,29)

Standard InChI Key:  NUUWLGXOHGOZLE-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5271468

    ---

Associated Targets(Human)

SSTR2 Tclin Somatostatin receptor 2 (1526 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SSTR4 Tclin Somatostatin receptor 4 (1125 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 390.49Molecular Weight (Monoisotopic): 390.2056AlogP: 4.08#Rotatable Bonds: 7
Polar Surface Area: 100.27Molecular Species: BASEHBA: 5HBD: 4
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 5#RO5 Violations (Lipinski):
CX Acidic pKa: 9.13CX Basic pKa: 9.92CX LogP: 2.71CX LogD: 1.25
Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.46Np Likeness Score: -0.63

References

1. Zhao J, Wang S, Markison S, Kim SH, Han S, Chen M, Kusnetzow AK, Rico-Bautista E, Johns M, Luo R, Struthers RS, Madan A, Zhu Y, Betz SF..  (2023)  Discovery of Paltusotine (CRN00808), a Potent, Selective, and Orally Bioavailable Non-peptide SST2 Agonist.,  14  (1.0): [PMID:36655128] [10.1021/acsmedchemlett.2c00431]

Source